Company Profile

Released time：2020-03-11

Global collaborative designing and development of original new drugs in the characteristic difficult field of "clinical unmet clinical needs".

The original design and development of characteristic original new drugs based on core innovation such as nucleic acid drug innovation, And focus on the transformation of "the first kilometer" and the landing of "the last kilometer".